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We have previously argued that the use of sodium ion gradient for
ATP synthesis is the ancestral modality of membrane bioenergetics
and that the Last Universal Cellular Ancestor (LUCA) was unlikely to
have proton-dependent energetics [1–4].
The evolutionary primacy of the sodium-dependent mem-
brane bioenergetics contradicts the common belief that the LUCA
possessed several proton pumps, such as cytochrome oxidase and
quinol: cytochrome c oxidoreductase, which are widespread
among bacteria and archaea. To address this conundrum, we
analyzed the phylogeny of the quinol: cytochrome c oxidoreduc-
tases (cytochrome bc1 complexes) and showed that the phylogenetic
tree of quinol: cytochrome c oxidoreductases did not follow the 16S
rRNA tree. We suggest that the common ancestor of the quinol:
cytochrome c oxidoreductases evolved within bacteria from a
membrane quinone oxidoreductase analogous to the complex II,
perhaps in response to the emergence of chlorophyll-based photo-
synthesis. Different archaeal phyla seem to have acquired different
types of quinol: cytochrome c oxidoreductases from bacteria by
lateral gene transfer on several independent occasions. A similar
scenario has been proposed for the evolution of the cytochrome
oxidases [5].
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Ascochlorin and ascofuranone are antibiotics produced by the
phytopathogenic fungus Ascochyta viciae, and both have closely
related prenylphenol structures like ubiquinol. Ascofuranone specif-
ically inhibits trypanosome alternative oxidase, and is considered to
be a promising candidate as a chemotherapeutic agent against African
trypanosomiasis. On the other hand, ascochlorin speciﬁcally acts at Qi
and Qo sites of cytochrome bc1 complex [1] to inhibit the electron
transport. We report the effects of ascochlorin on the pathogenic
yeast Candida albicans.
Ascochlorin also acted on the cytochrome bc1 complex to inhibit
the cyanide-sensitive respiration of C. albicans as well as antimycin A,
stigmatellin, and myxothiazol. Further, ascochlorin induces the
expression of nuclear-encoded cyanide-resistant alternative oxidase
gene, and inhibits the alternative oxidase activity. However, the
inhibitory effect was weaker (about 20%) than that of ascofuranone.
Interestingly, the amino acid residues of alternative oxidase involved
in the inhibitor (or ubiquinol)-binding are completely different from
those of cytochrome bc1 complex. Therefore, ascochlorin inhibits
both respiratory electron transports (cyanide-sensitive and cyanide-
resistant) in this yeast.
To examine the effects of respiratory inhibitors, C. albicans was
cultivated using a variety of carbon sources (glucose, acetate, ethanol
et al.) at several concentrations. Under all conditions tested, among the
respiratory inhibitors, antimycin A showed the most potent inhibition
on the aerobic growth, which was slightly increased by the combined
addition of ascofuranone. Ascochlorin had a little bit lesser growth
inhibition, which was increased in the presence of ascofuranone.
These results suggest that antimycin A induces little alternative
oxidase gene expression in spite of its helpful role in the aerobic
growth. Although ascochlorin was able to inhibit alternative oxidase
activity, this antibiotic induces alternative oxidase gene expression to
transport electrons to oxygen, thereby making a contribution to the
aerobic energy metabolism in C. albicans.
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The cytochrome bc1 complex (bc1) acts as a homodimeric proton
translocase, as reviewed in [1]. It oxidizes ubiquinol molecules (QP) in
the catalytic centers P via bifurcated reaction and reduces two distinct
substrates: the FeS cluster of the Rieske protein and, via the two
hemes b, the ubiquinone molecule located in another quinone
binding site N (QN), (according to the Mitchell's Q-cycle [2]).
Earlier we have shown that the reaction in the QP site is kinetically
coupled with the quinone reduction in the QN site, so that the
relocation of the FeS domain towards its electron acceptor cyto-
chrome c1 happens only after the ubiquinol formation in the center N
[3–5]. However, the mechanism of the suggested intra-monomer and
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inter-monomer coupling within the bc1 dimer [4, 6] has remained
elusive.
Here we have used large-scale molecular dynamics (MD) simula-
tions for tracking the communications within the bc1 of Rhodobacter
sphaeroides. The energy correlation analysis [7] revealed the possible
pathways for transmembrane propagation of information about the
redox state of the ubiqinone molecule in the QN site. Non-equilibrium
MD simulations of the bc1 with ubiquinone or ubisemiquinone in the
QN site, respectively, revealed the possible implication of helix E and
the ef-loop of cytochrome b in the intra-monomeric transmembrane
coupling. The MD simulations with occupied and unoccupied QP site
showed a possible pathway for the inter-monomeric communication
between the two QP sites of a bc1 dimer.
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Coenzyme Q (ubiquinone or Q) is a redox-active lipid essential
for electron and proton transport in the mitochondrial respiratory
chain. Q is also important in the mitochondrial inner membrane
because it serves as an antioxidant and it modulates the function of
the mitochondrial membrane transition pore [1]. Most Coq proteins
which participate in Q biosynthesis are present in a high molecular
mass multi-subunit complex in Saccharomyces cerevisiae. The absence
of a single Coq polypeptide from the complex causes a drastic
diminution of the steady state levels of some Coq proteins. In
consequence, only an early intermediate of the Q biosynthetic
pathway accumulates in Δcoq1–Δcoq9 strains [2].
We report that overexpression of the protein kinase Coq8 restores
the steady state levels of the Coq proteins in most Δcoq strains. The
stabilization of the Coq polypeptides leads to the accumulation of
Q biosynthetic intermediates [3]. These intermediates are likely
not competent to transfer electrons in the respiratory chain because
the strains are not capable of growing on non-fermentable carbon
sources. However, we suggest that some of these Q biosynthetic
intermediates have an antioxidant activity and are therefore able to
redox-cycle in vivo since they diminish the sensitivity of the
accumulating strains to poly-unsaturated fatty acids.
4-hydroxybenzoic acid is the precursor of the aromatic ring of Q.
We demonstrate that analogs of 4-hydroxybenzoic acid can be used
in vivo to either promote the synthesis of analogs of coenzyme Q [4]
or to bypass a deﬁcient Q biosynthetic step. In this later case, the use
of vanillic acid allowed the restoration of Q biosynthesis and
respiration in cells deﬁcient for the monooxygenase Coq6 [5].
Our data illustrate the possibility to generate Q analogs in vivo
which offers the opportunity to study the structural requirements of
Q for its different cellular functions.
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Using a stochastic simulation without any other hypotheses, we
have demonstrated the natural emergence of the Mitchell Q-cycle in
the functioning of the bc1 complex, with few short-circuits and a very
low occupancy of the reactive semiquinone species in the Qo site [1].
However, this simple model fails to explain both the inhibition by
antimycin of the bc1 complex and the accompanying increase in ROS
production.
To obtain inhibition of electron transfer to the high potential chain
in the presence of antimycin, it is necessary to block the electron
transfer from the reduced haem bL to the semiquinone in the Qo site
(short-circuit or bypass of type 2) [2]. Incorporating this constraint in
our stochastic model, we obtain a sigmoid inhibition curve due to the
fact that when only one antimycin is bound per bc1 dimer, the
electron of the inhibited monomer systematically crosses the dimer
interface to reduce a quinone or a semiquinone species in the other
(free) Qi site (bL–bL path). Because this step is not limiting, the
activity is unchanged (compared to the activity of the free dimer).
Interestingly, this bL–bL pathway is almost exclusively taken in this
half-bound antimycin dimmer. In the free dimer, the natural faster
pathway is bL–bH on the same monomer (at least in the absence of
ΔμH+). The addition of the assumption of half-of-the-sites reactivity
to the previous hypothesis leads to a transient activation in the
antimycin titration curve preceding a quasi-complete inhibition at
antimycin saturation.
In accordance with the chemistry of quinone, we have examined
the possibility that the return of the electron from the reduced haem
bL to the semiquinone in Qo could be blocked if we take into account
the protons transfer and release from the Qo site accompanying the
electron transfer. However preliminary simulations show that it is not
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